vs

Side-by-side financial comparison of CHEMUNG FINANCIAL CORP (CHMG) and STEM, INC. (STEM). Click either name above to swap in a different company.

STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $23.8M, roughly 2.0× CHEMUNG FINANCIAL CORP). CHEMUNG FINANCIAL CORP runs the higher net margin — 32.5% vs -33.9%, a 66.4% gap on every dollar of revenue. On growth, CHEMUNG FINANCIAL CORP posted the faster year-over-year revenue change (20.3% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 0.2%).

Chemung Canal Trust Company is a New York State chartered trust company based in Elmira, New York. It was founded as a publicly traded bank in 1833.

StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.

CHMG vs STEM — Head-to-Head

Bigger by revenue
STEM
STEM
2.0× larger
STEM
$47.1M
$23.8M
CHMG
Growing faster (revenue YoY)
CHMG
CHMG
+35.8% gap
CHMG
20.3%
-15.6%
STEM
Higher net margin
CHMG
CHMG
66.4% more per $
CHMG
32.5%
-33.9%
STEM
Faster 2-yr revenue CAGR
STEM
STEM
Annualised
STEM
36.1%
0.2%
CHMG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CHMG
CHMG
STEM
STEM
Revenue
$23.8M
$47.1M
Net Profit
$7.7M
$-16.0M
Gross Margin
48.9%
Operating Margin
46.1%
-17.7%
Net Margin
32.5%
-33.9%
Revenue YoY
20.3%
-15.6%
Net Profit YoY
30.9%
68.8%
EPS (diluted)
$1.61
$-4.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHMG
CHMG
STEM
STEM
Q4 25
$23.8M
$47.1M
Q3 25
$28.8M
$38.2M
Q2 25
$10.1M
$38.4M
Q1 25
$25.7M
$32.5M
Q4 24
$25.9M
$55.8M
Q3 24
$24.3M
$29.3M
Q2 24
$23.4M
$34.0M
Q1 24
$23.7M
$25.5M
Net Profit
CHMG
CHMG
STEM
STEM
Q4 25
$7.7M
$-16.0M
Q3 25
$7.8M
$-23.8M
Q2 25
$-6.5M
$202.5M
Q1 25
$6.0M
$-25.0M
Q4 24
$5.9M
$-51.1M
Q3 24
$5.7M
$-148.3M
Q2 24
$5.0M
$-582.3M
Q1 24
$7.0M
$-72.3M
Gross Margin
CHMG
CHMG
STEM
STEM
Q4 25
48.9%
Q3 25
35.5%
Q2 25
33.4%
Q1 25
32.4%
Q4 24
-4.4%
Q3 24
21.2%
Q2 24
27.6%
Q1 24
-95.0%
Operating Margin
CHMG
CHMG
STEM
STEM
Q4 25
46.1%
-17.7%
Q3 25
35.0%
-33.6%
Q2 25
-87.2%
-34.8%
Q1 25
29.9%
-65.0%
Q4 24
29.0%
-84.4%
Q3 24
29.8%
-493.2%
Q2 24
26.8%
-1705.5%
Q1 24
38.3%
-267.0%
Net Margin
CHMG
CHMG
STEM
STEM
Q4 25
32.5%
-33.9%
Q3 25
27.1%
-62.2%
Q2 25
-63.9%
527.8%
Q1 25
23.4%
-76.9%
Q4 24
29.8%
-91.6%
Q3 24
23.5%
-506.3%
Q2 24
21.3%
-1712.6%
Q1 24
29.7%
-283.9%
EPS (diluted)
CHMG
CHMG
STEM
STEM
Q4 25
$1.61
$-4.40
Q3 25
$1.62
$-2.84
Q2 25
$-1.35
$-1.79
Q1 25
$1.26
$-0.15
Q4 24
$1.24
$-15.29
Q3 24
$1.19
$-18.24
Q2 24
$1.05
$-71.81
Q1 24
$1.48
$-0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHMG
CHMG
STEM
STEM
Cash + ST InvestmentsLiquidity on hand
$50.1M
$48.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$254.7M
$-249.4M
Total Assets
$2.7B
$308.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHMG
CHMG
STEM
STEM
Q4 25
$50.1M
$48.9M
Q3 25
$107.6M
$43.1M
Q2 25
$320.1M
$40.8M
Q1 25
$53.4M
$58.6M
Q4 24
$47.0M
$56.3M
Q3 24
$80.4M
$75.4M
Q2 24
$70.2M
$89.6M
Q1 24
$94.9M
$112.8M
Total Debt
CHMG
CHMG
STEM
STEM
Q4 25
Q3 25
Q2 25
$99.1M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CHMG
CHMG
STEM
STEM
Q4 25
$254.7M
$-249.4M
Q3 25
$245.3M
$-235.7M
Q2 25
$235.0M
$-214.1M
Q1 25
$228.3M
$-417.5M
Q4 24
$215.3M
$-398.4M
Q3 24
$220.7M
$-344.1M
Q2 24
$201.2M
$-203.2M
Q1 24
$197.1M
$371.6M
Total Assets
CHMG
CHMG
STEM
STEM
Q4 25
$2.7B
$308.9M
Q3 25
$2.7B
$362.6M
Q2 25
$2.9B
$379.2M
Q1 25
$2.8B
$405.1M
Q4 24
$2.8B
$437.4M
Q3 24
$2.8B
$537.8M
Q2 24
$2.8B
$691.5M
Q1 24
$2.8B
$1.3B
Debt / Equity
CHMG
CHMG
STEM
STEM
Q4 25
Q3 25
Q2 25
0.42×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHMG
CHMG
STEM
STEM
Operating Cash FlowLast quarter
$45.5M
$8.2M
Free Cash FlowOCF − Capex
$43.8M
FCF MarginFCF / Revenue
183.7%
Capex IntensityCapex / Revenue
7.1%
Cash ConversionOCF / Net Profit
5.88×
TTM Free Cash FlowTrailing 4 quarters
$71.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHMG
CHMG
STEM
STEM
Q4 25
$45.5M
$8.2M
Q3 25
$12.2M
$11.4M
Q2 25
$9.7M
$-21.3M
Q1 25
$7.2M
$8.5M
Q4 24
$29.8M
$-14.7M
Q3 24
$9.2M
$-9.4M
Q2 24
$6.5M
$-11.9M
Q1 24
$7.9M
$-621.0K
Free Cash Flow
CHMG
CHMG
STEM
STEM
Q4 25
$43.8M
Q3 25
$11.8M
Q2 25
$9.4M
Q1 25
$6.9M
Q4 24
$26.2M
Q3 24
$8.6M
Q2 24
$5.5M
Q1 24
$7.9M
FCF Margin
CHMG
CHMG
STEM
STEM
Q4 25
183.7%
Q3 25
41.1%
Q2 25
92.9%
Q1 25
26.7%
Q4 24
101.2%
Q3 24
35.2%
Q2 24
23.4%
Q1 24
33.1%
Capex Intensity
CHMG
CHMG
STEM
STEM
Q4 25
7.1%
Q3 25
1.4%
Q2 25
3.6%
Q1 25
1.3%
Q4 24
14.0%
Q3 24
2.5%
Q2 24
4.4%
Q1 24
0.3%
Cash Conversion
CHMG
CHMG
STEM
STEM
Q4 25
5.88×
Q3 25
1.57×
Q2 25
-0.11×
Q1 25
1.19×
Q4 24
5.04×
Q3 24
1.60×
Q2 24
1.30×
Q1 24
1.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons